# Intraoperative Frozen Section Analysis for Margin Status in Breast Conserving Therapy: a Retrospective 6-Year Experience at a Tertiary Centre in North East India

**Authors:** Dibyajyoti Deka, Clara Atieno Odhiambo, Abhijit Talukdar, B. B. Borthakur, Pompi Daimari Buragohain, Deep Jyoti Kalita, Gaurav Das, Shivaji Sharma

PMC · DOI: 10.1007/s13193-025-02301-z · Indian Journal of Surgical Oncology · 2025-05-06

## TL;DR

This study evaluates the accuracy of intraoperative frozen section analysis in predicting margin status during breast-conserving surgery in Indian patients.

## Contribution

The study provides a six-year retrospective analysis of frozen section accuracy in a tertiary center in North East India.

## Key findings

- Frozen section analysis had a sensitivity of 92.5% and specificity of 99.8% for margin status.
- The positive and negative predictive values were 94.8% and 99.8%, respectively.
- The overall accuracy of frozen section analysis was 99.63%.

## Abstract

Breast cancer is the commonest cancer among Indian women as it is globally. Margin status post lumpectomy remains an important predictor of local recurrence after breast conserving surgery. We set out to investigate the positive predictive value of intra operative frozen section analysis in a tertiary cancer center in North East India. Retrospective data from all women who underwent breast conserving Surgery (BCS) from 2017 to 2022 was included. Frozen section analysis reports were compared against final pathology reports. Comparison was in regard to margin status. Two hundred ten women underwent BCT, and mean age was 49.5 years. The sensitivity and specificity of frozen section was 92.5% (86.2–95.64% 95% CI) and 99.8% (62.23–99.9% 95% CI) respectively. The PPV and NPV was 94.8% (87.09–99.86% 95% CI) and 99.8% (95.53–99.9% 95 CI). Our analysis showed an accuracy of 99.63% (95.22–99.96%, 95% CI). We concluded that frozen section analysis is accurate and has a high positive predictive value and negative predictive value for margin status in breast conserving surgery.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** anxiety (MESH:D001007), DCIS (MESH:D002285), Cancer (MESH:D009369), Deaths (MESH:D003643), BCT (MESH:D061325), metastases (MESH:D009362), benign disease (MESH:D004194), Breast cancer (MESH:D001943), TNBC triple negative breast cancer (MESH:D064726)
- **Chemicals:** haematoxylin (MESH:D006416), anthracycline (MESH:D018943), NSABP B18 (-), paraffin (MESH:D010232), formalin (MESH:D005557), alcohol (MESH:D000438), taxane (MESH:C080625), eosin (MESH:D004801), methylene blue (MESH:D008751)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921065/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921065/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921065/full.md

---
Source: https://tomesphere.com/paper/PMC12921065